David Krieger

555 total citations
12 papers, 326 citations indexed

About

David Krieger is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, David Krieger has authored 12 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in David Krieger's work include Tuberculosis Research and Epidemiology (3 papers), Chemical Synthesis and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). David Krieger is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Chemical Synthesis and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). David Krieger collaborates with scholars based in United States, Germany and United Kingdom. David Krieger's co-authors include J. S. Muenter, R. B. Merrifield, B W Erickson, Giorgio Vidali, Vincent G. Allfrey, Holger Rüssmann, Nicolas Schönfeld, Stefan Niemann, Silke Polsfuß and Sabine Hofmann-Thiel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Chemical Physics.

In The Last Decade

David Krieger

12 papers receiving 309 citations

Peers

David Krieger

SPECT

MB

AMPO

ID

AS

U. Kretschmer Germany

Trent Conroy Australia

Jingqiao Wang China

Oussama Meroueh United States

Martin J. Smith United States

Hajime Takashima Japan

Robert E. Duke United States

K. Olaf Börnsen Switzerland

Alessandra Souza Barbosa Brazil

Victor A. Mikhailov United Kingdom

U. Kretschmer Germany

David Krieger

174 ×1.4

SPECT

174 ×1.5

MB

156 ×1.4

AMPO

61 ×1.1

ID

81 ×1.5

AS

Citations per year, relative to David Krieger David Krieger (= 1×) peers U. Kretschmer

Countries citing papers authored by David Krieger

Since Specialization

Citations

This map shows the geographic impact of David Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Krieger more than expected).

Fields of papers citing papers by David Krieger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Krieger. The network helps show where David Krieger may publish in the future.

Co-authorship network of co-authors of David Krieger

This figure shows the co-authorship network connecting the top 25 collaborators of David Krieger. A scholar is included among the top collaborators of David Krieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Krieger. David Krieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Polsfuß, Silke, Sabine Hofmann-Thiel, Matthias Merker, et al.. (2019). Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment. Clinical Infectious Diseases. 69(7). 1229–1231. 50 indexed citations

2.

Vesenbeckh, Silvan, David Krieger, Nicolas Schönfeld, et al.. (2016). Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis. Tuberculosis. 98. 27–29. 11 indexed citations

3.

Krieger, David, Silvan Vesenbeckh, Nicolas Schönfeld, et al.. (2015). Minimal inhibitory concentrations (MICs) of mefloquine:in vitroactivity against MDR- and nonMDR-Tb strains. PA3327–PA3327. 1 indexed citations

4.

Vesenbeckh, Silvan, David Krieger, Nicolas Schönfeld, et al.. (2015). Neuroleptic drugs as potential adjuvants in the treatment of MDR-TB: Minimal inhibitory concentrations (MICs) of different phenothiazines againstM. tuberculosis. PA3329–PA3329. 1 indexed citations

5.

Kern, Winfried V., et al.. (2008). Lemierre-Syndrom mit Milzabszessen. DMW - Deutsche Medizinische Wochenschrift. 117(40). 1513–1517. 2 indexed citations

6.

Krieger, David, et al.. (2007). HEMODIALYSER MEMBRANES ALLOW FOR REMOVAL OF ARGATROBAN. Journal of Thrombosis and Haemostasis. 5. P–S. 4 indexed citations

7.

Benson, Lee, et al.. (1984). Hepatic encephalopathy after portacaval shunt in a noncirrhotic child. The Journal of Pediatrics. 105(3). 439–441. 14 indexed citations

8.

Krieger, David, Giorgio Vidali, Bruce W. Erickson, Vincent G. Allfrey, & R. B. Merrifield. (1979). The synthesis of diacetylated histone H4-(1–37) for studies on the mechanism of histone deacetylation. Bioorganic Chemistry. 8(4). 409–427. 12 indexed citations

9.

Krieger, David, et al.. (1977). Molecular beam electric resonance study of formaldehyde, thioformaldehyde, and ketene. The Journal of Chemical Physics. 67(4). 1576–1586. 151 indexed citations

10.

Crane‐Robinson, Colyn, Hiroaki Hayashi, Peter D. Cary, et al.. (1977). The Location of Secondary Structure in Histone H4. European Journal of Biochemistry. 79(2). 535–548. 14 indexed citations

11.

Krieger, David, B W Erickson, & R. B. Merrifield. (1976). Affinity purification of synthetic peptides.. Proceedings of the National Academy of Sciences. 73(9). 3160–3164. 36 indexed citations

12.

Krieger, David, Robert Levine, R. B. Merrifield, Giorgio Vidali, & Vincent G. Allfrey. (1974). Chemical Studies of Histone Acetylation. Journal of Biological Chemistry. 249(1). 332–334. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact